pirtobrutinib

News mentioning pirtobrutinib · Wikidata · RSS

Top stories

Latest

1. Jaypirca approval expanded to include treatment-naive CLL, small lymphocytic lymphomahealio.com · 2026-10-02 20:59 UTC · story
2. FDA Approves Pirtobrutinib for Previously Untreated CLL/SLLpharmacytimes.com · 2026-10-02 20:55 UTC · story
3. FDA Approves Jaypirca as First-Line Treatment for CLL and SLLcuretoday.com · 2026-10-02 19:51 UTC · story
4. Lilly's Jaypirca (pirtobrutinib), the first-and-only approved non-covalent BTK inhibitor, receives expanded indication from U.S. FDA for certain patients with previously untreated CLL/SLLprnewswire.com · 2026-10-02 19:30 UTC · story
5. Innovent's Jaypirca Gets Expanded NMPA Approval For CLL/SLLrttnews.com · 2026-09-28 10:39 UTC · story